21Shares reported a significant contraction in its TOXR exchange-traded product during the first half of 2024. The fund's asset base eroded by 54%, driven largely by the downward price action of XRP and a wave of capital redemptions. This decline culminated in a $13.4 million loss, highlighting the high sensitivity of single-asset crypto products to prolonged market drawdowns and shifting investor sentiment.
This development comes as the broader crypto market navigates a complex regulatory landscape in the United States. While the SEC's long-standing legal battle with Ripple Labs remains a focal point for XRP investors, the heavy outflows from TOXR suggest a pivot in institutional appetite toward more established spot Bitcoin and Ethereum products. The redemption pressure seen early in the year underscores a 'risk-off' sentiment that dominated XRP's specific market segment during the reporting period.
Despite the grim H1 figures, the report notes that net issuance actually turned positive in the second quarter, indicating a potential bottoming out of investor sentiment. Traders should closely monitor XRP’s support levels and watch for any shift in institutional flows back into altcoin ETPs as a sign of returning confidence. A sustained recovery will likely depend on the definitive resolution of Ripple's remaining legal hurdles and a broader resurgence in altcoin liquidity.